日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines

SPEAC网络研讨会报告(2023年9月22日):感音神经性听力损失、拉沙病毒病和疫苗

Reed, Nicholas S; Brewer, Carmen C; Akintunde, Gideon; Blackie, Faustina F; Charles, Lovelyn; Fast, Patricia; Lambert, Paul-Henri; Okogbenin, Sylvanus; Paessler, Slobodan; Pinschewer, Daniel D; Top, Karina A; Black, Steven B; Dekker, Cornelia L

Age-related changes in the immune system and challenges for the development of age-specific vaccines

免疫系统的年龄相关变化以及针对特定年龄段疫苗研发面临的挑战

Doherty, T Mark; Weinberger, Birgit; Didierlaurent, Arnaud; Lambert, Paul-Henri

Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine

一项双盲、安慰剂对照、剂量递增研究,旨在评估表位特异性化学定义纳米颗粒呼吸道合胞病毒疫苗的安全性和免疫原性

Leroux-Roels, Isabel; Bruhwyler, Jacques; Stergiou, Lilli; Sumeray, Mark; Joye, Jasper; Maes, Cathy; Lambert, Paul-Henri; Leroux-Roels, Geert

Advanced vaccinology training globally: Update and impact of the COVID-19 crisis

全球高级疫苗学培训:最新进展及新冠疫情危机的影响

Dochez, Carine; Duclos, Philippe; MacDonald, Noni; Steffen, Christoph; Lambert, Paul-Henri

Novel vaccine safety issues and areas that would benefit from further research

疫苗安全方面的新问题以及需要进一步研究的领域

Salmon, Daniel A; Lambert, Paul Henri; Nohynek, Hanna M; Gee, Julianne; Parashar, Umesh D; Tate, Jacqueline E; Wilder-Smith, Annelies; Hartigan-Go, Kenneth Y; Smith, Peter G; Zuber, Patrick Louis F

Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

疫苗相关增强疾病:病例定义及免疫接种安全数据收集、分析和呈现指南

Munoz, Flor M; Cramer, Jakob P; Dekker, Cornelia L; Dudley, Matthew Z; Graham, Barney S; Gurwith, Marc; Law, Barbara; Perlman, Stanley; Polack, Fernando P; Spergel, Jonathan M; Van Braeckel, Eva; Ward, Brian J; Didierlaurent, Arnaud M; Lambert, Paul Henri

Erratum: Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination

更正:作者更正:人接种rVSV-ZEBOV埃博拉病毒疫苗后,自然杀伤(NK)细胞的快速剂量依赖性调节和细胞因子反应。

Pejoski, David; de Rham, Casimir; Martinez-Murillo, Paola; Santoro, Francesco; Auderset, Floriane; Medaglini, Donata; Pozzi, Gianni; Vono, Maria; Lambert, Paul-Henri; Huttner, Angela; Haks, Mariëlle C; Ottenhoff, Tom H M; Villard, Jean; Siegrist, Claire-Anne

A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner

一种含有TLR7/8激动剂的基于DOEPC的阳离子脂质体配方,通过以I型干扰素非依赖性但NF-κB依赖性的方式持续募集高度活化的单核细胞,从而发挥其佐剂作用。

Auderset, Floriane; Belnoue, Elodie; Mastelic-Gavillet, Beatris; Lambert, Paul-Henri; Siegrist, Claire-Anne

Advanced vaccinology education: Landscaping its growth and global footprint

高级疫苗学教育:展望其发展和全球影响力

Asturias, Edwin J; Duclos, Philippe; MacDonald, Noni E; Nohynek, Hanna; Lambert, Paul-Henri

Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

CEPI/BC 2020年3月12-13日会议共识总结报告:评估COVID-19疫苗疾病增强的风险

Lambert, Paul-Henri; Ambrosino, Donna M; Andersen, Svein R; Baric, Ralph S; Black, Steven B; Chen, Robert T; Dekker, Cornelia L; Didierlaurent, Arnaud M; Graham, Barney S; Martin, Samantha D; Molrine, Deborah C; Perlman, Stanley; Picard-Fraser, Philip A; Pollard, Andrew J; Qin, Chuan; Subbarao, Kanta; Cramer, Jakob P